Leads Biolabs’ Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL-051
NANJING, China, August 4, 2026 Leads Biolabs announced that its partner Oblenio Bio, a company jointly established with Aditum...
first patient dosed
Advertisement
Akeso Doses First Patient in HER3 ADC Lung Cancer Trial
Hong Kong, July 27, 2026 Akeso, Inc. has announced that the first patient has been dosed in the Phase...
Akeso Starts Phase II Trial of AK146D1 for Advanced NSCLC
HONG KONG, July 20, 2026 Akeso, Inc. has announced a significant milestone in its oncology pipeline with the first...
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx
MELBOURNE, Australia, and INDIANAPOLIS, Ind., July 21, 2026 Telix Pharmaceuticals announced that the first patient has been dosed in...
Kinaset Doses First Patient in Phase 2b Frevecitinib Trial
BOSTON, MA, July 20, 2026 Kinaset Therapeutics announced that the first patient has been dosed in the Phase 2b...
Advertisements
Immunome Doses First Patient in Phase 1 IM-3050 Radioligand Therapy Trial
BOTHELL, Wash., July 20, 2026 Immunome, Inc. (Nasdaq: IMNM) announced that the first patient has been dosed in the...
92Bio Doses First Patient in Phase 1 Trial of NTB-928 for Platinum-Resistant Ovarian Cancer
SAN DIEGO, Calif., July 1, 2026 92Bio, Inc. announced that the first patient has been dosed in its Phase...
Immunome Doses First Patient in Phase 1 Trial of IM-1617
BOTHELL, Wash., June 11, 2026 Immunome, Inc. announced the first patient has been dosed in a Phase 1 first-in-human...
Vectory Doses First Patient in Phase 1/2 ALS Trial
Amsterdam, Netherlands | February 9 2026 — Vectory Therapeutics has announced that the first participant has been dosed in...
Ensem Doses First China Patient in Global PI3Kα Trial
WALTHAM, Mass. & SHANGHAI, Feb. 2, 2026 — Ensem Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, announced that it...
Advertisement
